Paper36902175
When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases.
Boi D and 4 others. Int J Mol Sci, 2023. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases. Papers, record 36902175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36902175
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Serine-Threonine Kinases | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Aurora Kinase B | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Phosphates |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AIRC IG-2021 ID-25648 | Italian Association for Cancer Research | PubMed | ||
| AIRC MFAG-2017 ID-20447 | Italian Association for Cancer Research | PubMed |
Source PubMed
References260
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,719,948 | Present and Future Perspective on PLK1 Inhibition in Cancer Treatment. | Front Oncol | 2022 | https://conductscience.org/library/papers/35719948 | PubMed |
| 2 | 39,778,578 | Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders. | Cell Chem Biol | 2025 | https://conductscience.org/library/papers/39778578 | PubMed |
| 3 | 19,060,929 | The aurora kinase A regulates GSK-3beta in gastric cancer cells. | Oncogene | 2009 | https://conductscience.org/library/papers/19060929 | PubMed |
| 4 | 19,690,609 | A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. | PLoS One | 2009 | https://conductscience.org/library/papers/19690609 | PubMed |
| 5 | 6,513,926 | Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. | Mol Cell Biol | 1984 | https://conductscience.org/library/papers/6513926 | PubMed |
| 6 | 30,405,751 | Effects of PLK1 on proliferation, invasion and metastasis of gastric cancer cells through epithelial-mesenchymal transition. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30405751 | PubMed |
| 7 | 27,313,991 | The Quest for Targets Executing MYC-Dependent Cell Transformation. | Front Oncol | 2016 | https://conductscience.org/library/papers/27313991 | PubMed |
| 8 | 21,821,029 | Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53. | FEBS Lett | 2011 | https://conductscience.org/library/papers/21821029 | PubMed |
| 9 | 20,399,964 | MYC in oncogenesis and as a target for cancer therapies. | Adv Cancer Res | 2010 | https://conductscience.org/library/papers/20399964 | PubMed |
| 10 | 34,477,871 | A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy. | Neuro Oncol | 2022 | https://conductscience.org/library/papers/34477871 | PubMed |
| 11 | 2,997,622 | L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. | Nature | 1985 | https://conductscience.org/library/papers/2997622 | PubMed |
| 12 | 32,153,186 | Discovery of Thieno[2,3-d]pyrimidine-Based Hydroxamic Acid Derivatives as Bromodomain-Containing Protein 4/Histone Deacetylase Dual Inhibitors Induce Autophagic Cell Death in Colorectal Carcinoma Cells. | J Med Chem | 2020 | https://conductscience.org/library/papers/32153186 | PubMed |
| 13 | 30,650,356 | p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value. | Cell Rep | 2019 | https://conductscience.org/library/papers/30650356 | PubMed |
| 14 | 19,111,882 | Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19111882 | PubMed |
| 15 | 25,491,234 | Pim kinases in hematological malignancies: where are we now and where are we going? | J Hematol Oncol | 2014 | https://conductscience.org/library/papers/25491234 | PubMed |
| 16 | 226,888 | Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. | Nature | 1979 | https://conductscience.org/library/papers/226888 | PubMed |
| 17 | 20,708,655 | The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme? | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20708655 | PubMed |
| 18 | 23,535,202 | PKA: lessons learned after twenty years. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23535202 | PubMed |
| 19 | 31,259,656 | The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma. | Leuk Lymphoma | 2019 | https://conductscience.org/library/papers/31259656 | PubMed |
| 20 | 29,760,449 | Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. | Sci Rep | 2018 | https://conductscience.org/library/papers/29760449 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,794,667 | The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794667 | PubMed |
| 42,595,906 | Photoproximity labeling of c-Myc reveals SLK as a cancer-specific co-regulator. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/42595906 | PubMed |
| 42,424,412 | Compressive stress inhibits proliferation in AsPC-1 pancreatic cancer cells and reduction of Myc protein. | PLoS One | 2026 | https://conductscience.org/library/papers/42424412 | PubMed |
| 41,331,192 | CCA-1.1 Destabilizes MYC proteins to induce irreversible anti-proliferative effects in hepatocellular carcinoma. | Med Oncol | 2025 | https://conductscience.org/library/papers/41331192 | PubMed |
| 41,256,636 | Photoproximity labeling of c-Myc reveals SLK as a cancer specific co-regulator. | bioRxiv | 2025 | https://conductscience.org/library/papers/41256636 | PubMed |
| 41,129,693 | Thyroid Hormone Receptor β Suppresses Cancer Cell Activity by Differential Regulation of Glycogen Metabolism. | Endocrinology | 2025 | https://conductscience.org/library/papers/41129693 | PubMed |
| 40,241,199 | The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40241199 | PubMed |
| 38,275,056 | Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer. | Curr Cancer Drug Targets | 2024 | https://conductscience.org/library/papers/38275056 | PubMed |
| 38,132,127 | The Identification of Nuclear FMRP Isoform Iso6 Partners. | Cells | 2023 | https://conductscience.org/library/papers/38132127 | PubMed |
Genes72
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36902175
GET https://conductscience.org/api/papers/v1/36902175/references?page=2